The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

@article{Garside2007TheEA,
  title={The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.},
  author={R. G. Garside and Martin Pitt and Rob Anderson and Gabriel Rogers and Matthew Dyer and Stuart Mealing and Margaret Somerville and Alison Price and Ken Stein},
  journal={Health technology assessment},
  year={2007},
  volume={11 45},
  pages={iii-iv, ix-221}
}
OBJECTIVES To assess the clinical and cost-effectiveness of adjuvant carmustine wafers (BCNU-W) and also of adjuvant and concomitant temozolomide (TMZ), compared with surgery with radiotherapy. DATA SOURCES Electronic databases were searched up to August 2005. REVIEW METHODS Included trials were critically appraised for key elements of internal and… CONTINUE READING